Guaifenesin (API) Market Statistics | Focus On Estimation, R

Pune, Maharashtra, India, October 18 2022 (Wiredrelease) Prudour Pvt. Ltd –:Guaifenesin is an active pharmaceutical ingredient used in cough syrup and cold medicines. It is an expectorant, which means it helps to thin and loosen mucus in the lungs. Guaifenesin is the generic name for the active ingredient in Mucinex...

Related Keywords

New York , United States , Japan , United Kingdom , Argentina , Pune , Maharashtra , India , Brazil , China , South Africa , Colombia , United Arab Emirates , Canada , Russia , Germany , Mexico , Yuan Cheng , Guangdong , New Zealand , Nigeria , Egypt , Israel , Italy , Saudi Arabia , Chile , Peru , France , Spain , Turkey , America , Iwaki Seiyaku , Haizhou Pharma , Gennex Lab , Global Business Development Teams , Research Methodology , Wiredrelease News Department , Pfizer , Yuan Cheng Group , Top Companies , Speculation Business Research League , Top Companies Participating , Business Research , Market Segments Evaluated , Middle East , Africa Guaifenesin , North America Guaifenesin , Asia Pacific Guaifenesin , Southeast Asia , South America Guaifenesin , Europe Guaifenesin , Global Guaifenesin , Impact Study , Potential Impact , Impact Assessment , America Guaifenesin , Pacific Excluding Japan , Greater China , Business Development Teams , Powered By Prudour , York City ,